Among them, SERCA (sarco/endoplasmic reticulum calcium ATPase) inhibitors have been identified as potential regulators of leukemia-associated NOTCH1 mutant signaling and cell cycle progression and expansion of T-ALL xenografts [83]. Here, NOTCH1 is linked to leukemia.